Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftaroline fosamil in elderly subjects with CABP
NCT01666743Phase 4Withdrawn
- Sponsor
- Forest Laboratories
- Start
- Nov 2012
- Primary completion
- Sep 2013
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ceftaroline fosamil in community-acquired bacterial pneumonia (CAP), sponsored by Forest Laboratories. Planned start Nov 2012; status: withdrawn.
02
Drugs
ceftaroline fosamil
03
Conditions
community-acquired bacterial pneumonia (CAP)
Beyond the preview
Go deeper on NCT01666743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01666743.